Pharmena S.A. (WSE:PHR)
Poland · Delayed Price · Currency is PLN 3.260
0.00 (0.00%)
Sep 4, 2026, 2:27 PM CET
Pharmena Market Cap
Pharmena has a market cap or net worth of 36.31 million as of September 4, 2026. Its market cap has decreased by -6.86% in one year.
Market Cap
36.31M
Enterprise Value
36.20M
Revenue
1.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.26
ChartMarket Cap Chart
Since August 25, 2008, Pharmena's market cap has decreased from 171.99M to 36.31M, a decrease of -78.89%. That is a compound annual growth rate of -8.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 36.31M | 25.38% |
| Dec 30, 2025 | 28.96M | -32.11% |
| Dec 30, 2024 | 42.66M | -46.06% |
| Dec 29, 2023 | 79.08M | 26.79% |
| Dec 30, 2022 | 62.37M | -29.20% |
| Dec 30, 2021 | 88.10M | -10.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 497.56M |
| Captor Therapeutics Spolka Akcyjna | 454.27M |
| Bioceltix | 438.15M |
| Ryvu Therapeutics | 392.58M |
| BIOTON | 323.71M |
| Synthaverse | 222.39M |
| Molecure | 132.68M |
| Poltreg | 130.75M |